CardioNet, Inc. (NASDAQ:BEAT) announced today that LifeWatch Corp. and CardioNet have entered into a settlement agreement pursuant to which the parties have amicably agreed to resolve the lawsuit between them, with dismissal by both sides of all claims pending in the lawsuit. Terms of the agreement are confidential.

Arie Cohen, President and Chief Executive Officer, commented: “We are pleased to have this behind us, and we look forward to continuing the strong momentum we have achieved in recent quarters.”

About CardioNet

CardioNet, Inc. is the leading provider of ambulatory, continuous, real-time outpatient management solutions for monitoring relevant and timely clinical information regarding an individual’s health. CardioNet’s initial efforts are focused on the diagnosis and monitoring of cardiac arrhythmias, or heart rhythm disorders, with a solution that it markets as the CardioNet System. More information can be found at

CardioNet, Inc.
Marty Galvan
Investor Relations